Iran war impact
Based on the available corporate filings and financial reports as of March 2026, the impact of the Middle East conflict on Aptus Pharma Ltd. appears to be minimal to neutral, primarily because the company is predominantly focused on the d...
Read More
355.00
5.00
(1.43%)
4,000
BSE Volume
BSE 09 Apr, 2026 3:31 PM (IST)